Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DZX8J3
|
|||
| Drug Name |
JK07
|
|||
| Drug Type |
Fusion protein
|
|||
| Indication | Heart failure with preserved ejection fraction [ICD-11: BD11.0] | Phase 1 | [1] | |
| Company |
SalubrisBio
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT05322616) A Randomized, Double-Blind, Placebo-Controlled, Single-Ascending Dose Study to Assess the Safety and Tolerability of JK07 in Subjects With Heart Failure With Preserved Ejection Fraction (HFpEF). U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.